Publications

Development of an RNA aptamer as a therapeutic agent for synucleinopathies

 35
Development of an RNA aptamer as a therapeutic agent for synucleinopathies

Tags:

Previous Article

Cognitive symptoms in cerebral palsy from remote network

Next Article

RNA aptamer to treat synucleinopathies

Related Posts

RNA isoform diversity in human neurodegenerative diseases

RNA isoform diversity in human neurodegenerative diseases

 132

An integrated view of the structure and function of the human 4D nucleome

An integrated view of the structure and function of the...

 60

Acetylated cellulose suppresses body mass gain through gut commensals consuming host- accessible carbohydrates

Acetylated cellulose suppresses body mass gain through...

 133